Antidepressant repurposed in major fight against debilitating migraines
NCT ID NCT07385755
Summary
This study is testing whether the medication desvenlafaxine can help prevent frequent migraine attacks. It involves 440 adults who get migraines several times a month. Researchers will measure if taking the drug for 12 weeks reduces how often people get migraines and how bad they are.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430000, China
Conditions
Explore the condition pages connected to this study.